|
HY-126037-1mg
|
MedChemexpress LLC
|
(�)-ML 209 [CAS 1334526-14-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101771A-100mg
|
MedChemexpress LLC
|
(2-Chloropyridin-4-yl)methanamine hydrochloride [CAS 916210-98-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101771A-1mL
|
MedChemexpress LLC
|
(2-Chloropyridin-4-yl)methanamine hydrochloride [CAS 916210-98-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-100754B-10mg
|
MedChemexpress LLC
|
(2R,5S)-Ritlecitinib [CAS 1792180-79-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100754B-100mg
|
MedChemexpress LLC
|
(2R,5S)-Ritlecitinib [CAS 1792180-79-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100754B-25mg
|
MedChemexpress LLC
|
(2R,5S)-Ritlecitinib [CAS 1792180-79-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100754B-5mg
|
MedChemexpress LLC
|
(2R,5S)-Ritlecitinib [CAS 1792180-79-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100754B-50mg
|
MedChemexpress LLC
|
(2R,5S)-Ritlecitinib [CAS 1792180-79-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-116227-5mg
|
MedChemexpress LLC
|
(2S,3R)-LP99 [CAS 1808948-28-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-40354D-1mg
|
MedChemexpress LLC
|
(3R,4S)-Tofacitinib [CAS 1092578-46-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-40354D-10mg
|
MedChemexpress LLC
|
(3R,4S)-Tofacitinib [CAS 1092578-46-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-40354D-5mg
|
MedChemexpress LLC
|
(3R,4S)-Tofacitinib [CAS 1092578-46-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-40354C-1mg
|
MedChemexpress LLC
|
(3S,4S)-Tofacitinib [CAS 1092578-47-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-40354C-5mg
|
MedChemexpress LLC
|
(3S,4S)-Tofacitinib [CAS 1092578-47-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-134950-1mg
|
MedChemexpress LLC
|
(E)-C-HDMAPP (ammonium) [CAS 933030-60-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-15125-10mg
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-15125-100mg
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-15125-25mg
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-15125-5mg
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-15125-50mg
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-15125-1mL
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-10mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-100mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-25mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-117917-5mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
